The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
2 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $375,000 in first-year total cost, median $187,500.
Most frequent study sections
- Special Emphasis Panel[ZRG1 ETTN-M (50)]2
Most frequent institutions
- LAMNOTHERAPEUTICS, INC.1
- QUALIBER, INC.1
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2015 | On-demand releasing nano-VCR for effective neuroblastoma therapy1R43HD084021-01A1 | LI, YUANPEI | LAMNOTHERAPEUTICS, INC., CA | $225,000 | ZRG1 |
| 2014 | Development of NanoFludarabine for Pediatric Leukemia using LCP Nanotechnology1R43HD081732-01 | LI, JUN | QUALIBER, INC., NC | $150,000 | ZRG1 |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.